Last updated: April 25, 2026
What is Efudex and what form does the supply chain cover?
Efudex is the brand name for fluorouracil (5-FU) used as a topical therapy (historically for actinic keratoses). The supplier landscape depends on the product form sold in each market (most commonly topical cream under the Efudex brand in the United States).
Because suppliers differ by jurisdiction and product authorization (brand vs generic, pack strength, and dossier holder), “Efudex suppliers” is best treated as:
- Marketing authorization holders and brand owners / licensees for each country’s approved Efudex product
- Manufacturing site(s) listed in the regulatory product dossiers
- Wholesale distributors in-country (secondary layer)
The key point for business use is that “who supplies Efudex” is rarely one fixed manufacturer globally; it is a combination of authorization holder plus contract manufacturers plus local distributors.
Who supplies the active pharmaceutical ingredient (API) and how is it documented?
For fluorouracil, the API is typically manufactured by specialty API producers and supplied under commercial contract to formulation manufacturers. Under most regulatory regimes, the API supplier is reflected indirectly through:
- Finished product regulatory filings that cite the API manufacturer
- GMP inspection outcomes tied to named manufacturing sites
However, without a market-specific product label (country, pack strength, and NDC or equivalent) and without the regulatory dossier references for that exact Efudex presentation, it is not possible to list a defensible, complete set of named API suppliers that applies to all markets.
What is the practical supplier map for Efudex in the US?
In the United States, Efudex is/was marketed under the 5-FU topical brand. The supplier set needed for sourcing or diligence is:
- Brand marketing/labeler entity (U.S. label holder and distributor chain origin)
- Contract manufacturing sites that produce the cream
- Authorized wholesalers that distribute the labeled finished product into the pharmacy/clinic channel
Without the specific U.S. presentation (strength and package configuration), any attempt to name particular manufacturers and distributors risks mixing generic fluorouracil with the Efudex branded product.
What suppliers are used for fluorouracil topicals versus Efudex branded product?
A major sourcing pitfall is treating “fluorouracil topical” as equivalent to “Efudex.” In practice:
- The market includes brand Efudex and generic fluorouracil topical creams
- Generics commonly have different label holders and manufacturing sites
- Distributor networks differ by manufacturer and labeler
So, any list titled “Efudex suppliers” must stay tied to the brand presentation (not just the API or class).
Supplier diligence checklist for Efudex (brand-specific)
For a supplier shortlist that holds up in procurement and compliance:
1) Confirm the exact Efudex presentation
Match these to the commercial listing:
- Country and market
- Pack size and strength
- Product code (US NDC or equivalent)
2) Obtain the finished-product GMP and labeling chain
You should capture:
- Labeler/marketing authorization holder
- Manufacturing site address(es)
- Packager (if separate)
- Responsible parties for quality release
3) Map upstream API manufacturing
In dossiers and audits, capture:
- API manufacturer name and site
- Intermediate synthesis and GMP status (as stated)
4) Validate distribution eligibility
For wholesalers/secondary suppliers:
- Authorized distribution status for the specific labeler
- Temperature and handling controls (topicals still have packaging controls and stability requirements)
- Recalls and complaint history linked to the specific manufacturer lot
Key Takeaways
- “Efudex suppliers” is not a single global set; it varies by country and exact labeled presentation.
- A defensible supplier list must be tied to the brand Efudex product code/strength/pack and must identify both the labeler/authorization holder and the named manufacturing sites.
- Mixing generic fluorouracil topicals with Efudex branded product will produce incorrect supplier mappings.
FAQs
1) Are API suppliers the same as Efudex finished-product suppliers?
No. Efudex supply involves upstream API sourcing and downstream formulation/packaging under the finished-product manufacturer and labeler.
2) Can I source Efudex by searching for “fluorouracil topical manufacturers”?
That approach can return generic or different authorization holders. Efudex brand-specific sourcing requires matching the exact branded presentation.
3) Do suppliers vary by country even if the brand name is the same?
Yes. Regulatory authorization, contract manufacturing, and local distribution networks differ by market.
4) What documentation best proves a supplier for Efudex?
Finished-product labeling/regulatory listing and GMP manufacturing site information tied to the specific product presentation.
5) How do I avoid supplier errors when Efudex coexists with generics?
Lock the sourcing request to the exact brand product strength, pack configuration, and product code; confirm labeler and manufacturing sites.
References
[1] U.S. Food and Drug Administration (FDA). Drugs@FDA: Fluorouracil topical (brand and generic listings). https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Medicines Agency (EMA). Medicines database (if applicable by market authorization). https://www.ema.europa.eu/en/medicines
